Morning Briefing
Summaries of health policy coverage from major news organizations
Viewpoints: RSV Can't Be Overlooked Anymore; MAHA's Influence Appears To Be Fading
CIDRAP: RSV—The Middle Child Of Respiratory Season Who Deserves More Attention
The RSV vaccine is different from the vaccines for flu or covid. It does not have a reputation problem or a trust problem. It has an awareness problem. Most people do not know what RSV is, do not know they are at risk, and do not know there is something they can do about it. (Jess Steier, 5/19)
The New York Times: MAHA Is No Longer Useful To Trump
Robert F. Kennedy Jr.’s MAHA movement has reshaped the public health debate. But if the coalition behind it begins to fracture, what comes next? (Tressie McMillan Cottom, Alexandra Sifferlin and David Wallace-Wells, 5/21
Stat: Can The FDA Ever Recover From The Trump Administration?
I was at the annual American Society of Gene & Cell Therapy (ASGCT) meeting in Boston when news broke last week that Food and Drug Administration Commissioner Marty Makary was being ousted. The general reaction from my colleagues seemed to be a resigned sense that chaos is the new norm. (Paul Knoepfler, 5/21)
Stat: Ebola Taught Me Whose Suffering The World Sees
Amid another Ebola outbreak, hundreds of Africans are sick, displaced, fearful, or dead. Health care workers across Central Africa are once again caring for patients in overstretched hospitals with limited supplies, uncertain staffing, and enormous personal risk. Yet, as has happened before, the story has suddenly become about an American — in this case, a missionary and physician who became infected. (Krutika Kuppalli, 5/20)
Stat: Living With Bullet Fragments In The Body Can Have Long-Term Medical Consequences
Oronde McClain was only 10 when he was shot in the head while caught in the gunfire of a drive-by shooting. He had to learn how to walk and talk again after an eight-week coma and the removal of one-third of his brain. (Adeiyewunmi [Ade] Osinubi, 5/21)
